Bernhard Ø. Palsson, Ph.D.

Bernhard Ø. Palsson is Professor of Bioengineering and Adjunct Professor of Medicine at the University of California, San Diego.

He is the author of over 140 scientific articles and 20 U.S. patents, many of which are in the area of hematopoietic stem cell transplantation, cell culture technology, bioreactor design, gene transfer, and metabolic engineering. He recieved his Ph.D. from the University of Wisconsin-Madison in Chemical Engineering in 1984 and is on the editorial boards of several leading peer-reviewed bioengineering and biotechnology journals.

Professor Palsson held a faculty position at the University of Michigan from 1984 to 1995. He is the recipient of an Institute of International Education Fellowship(1977), a Rotary Fellowship (1979), and a NATO fellowship (1984). He was named the G.G. Brown Associate Professor at Michigan in 1989, a Fullbright Fellow in 1995, and an Ib Henriksen Fellow in 1996 and the Olaf Hougen Professor at the University of Wisconsin in 2000.

His current research at UCSD focuses on the construction of genome-scale models of cellular metabolism, and on stem cell fate processes.

In 1988, Professor Palsson co-founded a biotechnology company, Aastrom Biosciences, where he served as the Vice President of Developmental Research for two years. He is also founder or co-founder of Oncosis, a company that is focused on the purging of occult tumor cells in autologous bone marrow transplants; Genomatica, a company that is focused on in silico biology; and the Iceland Genomics Corporation, a company that is focused on tracing the genetic basis for common human diseases in the Icelandic population.